NEW YORK – CareDx and Johns Hopkins University announced on Thursday a partnership to launch the Allosure Lung Allograft Remote Monitoring (ALARM) Partnership.
During the COVID-19 pandemic, Johns Hopkins has adopted CareDx's RemoTraC for high-risk populations of kidney, heart, and lung transplant patients who need close medical monitoring. RemoTraC is a remote home-based blood draw product that uses mobile phlebotomy for AlloSure and AlloMap surveillance tests, as well as for other standard monitoring tests.